Blucora Inc (INSP) Big Money Sentiment Improved in Q2 2018 to 1.25

Positions for Blucora Inc (INSP)

In 2018 Q2 Blucora Inc (INSP) big money sentiment increased to 1.25, SEC.gov filings reveal. That’s up 0.20, from 2018Q1’s 1.05. 94 active investment managers opened new and increased equity positions, while 75 decreased and sold positions in Blucora Inc so the sentiment is better. Funds own 43.70 million shares, up from 43.55 million shares in 2018Q1. Funds holding Blucora Inc in top 10 increased from 2 to 3 for an increase of 1. 17 Investors Sold All; 58 Reduced Holdings; 59 increased stakes while 35 active investment managers bought stakes.

Most Blucora Inc Investors

Harvest Capital Strategies Llc owns 725,000 shares in Blucora Inc as of 2018 Q2. As of 2018 Q2, 432,956 shares of Blucora Inc are owned by Hillcrest Asset Management Llc. Oberweis Asset Management Inc reported 209,614 shares. The Wisconsin-based fund Timpani Capital Management Llc have invested about 0.83% of the investment professional’s stock portfolio in Blucora Inc. The California-based fund Park West Asset Management Llc looks positive on Blucora Inc, possessing 550,000 shares.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea .The firm is valued at $990.60 million. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.Last it reported negative earnings.

Ticker’s shares touched $46.39 during the last trading session after 11.38% change.Inspire Medical Systems, Inc. is after having 0.00% since November 10, 2017. INSP has 661,398 volume or 327.22% up from normal. INSP underperformed the S&P500 by 15.62%.

Aperio Gru Lc reported 0% in Inspire Medical Systems, Inc. (NYSE:INSP). Tiaa Cref Inv Mngmt Limited Com has 101,648 shs. State Board Of Administration Of Florida Retirement System owns 37,758 shs or 0% of their US capital. Barclays Public Limited Co holds 38,356 shs. Bnp Paribas Arbitrage Sa accumulated 3,103 shs or 0% of the stock. Fincl Bank Of Ny Mellon Corp holds 0.01% or 550,218 shs in its capital. Parkside Commercial Bank Tru holds 0% or 41 shs. One Natl Association stated it has 14,350 shs. Texas-based Bridgeway Capital Mngmt Inc has invested 0.06% in Inspire Medical Systems, Inc. (NYSE:INSP). Jpmorgan Chase & Co invested in 525,047 shs or 0% of the stock. Global X Management Limited Liability Com has invested 0.08% in Inspire Medical Systems, Inc. (NYSE:INSP). Wells Fargo Mn holds 367,604 shs or 0% of its capital. 47,339 were accumulated by Citigroup. 288,311 were reported by Arrowstreet Capital Lp. Louisiana State Employees Retirement reported 21,000 shs stake.

Inspire Medical Systems, Inc. had 2 selling transactions and 0 buys since May 11, 2018. This’s net activity of $3.11 million. 79,000 shs valued at $2.98 million were sold by Clendening John S on Monday, July 16.

Inspire Medical Systems, Inc. (NYSE:INSP) Ratings Coverage

In total 6 analysts cover Inspire Medical Systems (INSP). “Buy” rating has 4, “Sell” are 0, while 2 are “Hold”. (INSP) has 67% bullish analysts. 6 are the (INSP)’s ratings reports on 10 Nov 2018 according to StockzIntelligence Inc. On Tuesday, May 29 Bank of America initiated the shares of INSP in report with “Hold” rating.

For more Inspire Medical Systems, Inc. (NYSE:INSP) news published recently go to: Benzinga.com, Nasdaq.com, Benzinga.com, Globenewswire.com or Globenewswire.com. The titles are as follows: “88 Biggest Movers From Yesterday” published on November 08, 2018, “Inspire Medical Systems, Inc. to Present at the Stifel 2018 Healthcare Conference” on October 25, 2018, “The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos …” with a publish date: November 06, 2018, “Inspire Medical Systems, Inc. to Report Third Quarter 2018 Financial Results November 6, 2018” and the last “Inspire Medical Systems, Inc. Announces Presentation of Clinical Efficacy Data for Inspire Therapy for Treatment of …” with publication date: October 17, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.